Showing results (1801-1810 of 2,011) with videos related to

Sort By:
Pageof 202
Cell Host & Microbe|November 24, 2019
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in MiceIuliia M Gilchuk, Sandhya Bangaru, Pavlo Gilchuk, et al.
The Lancet. Global Health|June 17, 2022
Mobile health school screening and telemedicine referral to improve access to specialty care in rural Alaska: a cluster- randomised controlled trialSusan D Emmett, Alyssa Platt, Elizabeth L Turner, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2021
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunizationHannah L Turner, Raiees Andrabi, Christopher A Cottrell, et al.
American Journal of Human Genetics|May 29, 2003
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North AmericaJorge R Toro, Michael L Nickerson, Ming-Hui Wei, et al.
Physical Review Letters|February 29, 2020
Observational Evidence for Stochastic Shock Drift Acceleration of Electrons at the Earth's Bow ShockT Amano, T Katou, N Kitamura, et al.
Cell|May 18, 2019
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceSandhya Bangaru, Shanshan Lang, Michael Schotsaert, et al.
Science Advances|June 18, 2020
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersiteBartek Nogal, Laura E McCoy, Marit J van Gils, et al.
Cell Reports|April 14, 2017
Cooperativity Enables Non-neutralizing Antibodies to Neutralize EbolavirusKatie A Howell, Jennifer M Brannan, Christopher Bryan, et al.
Cytotherapy|August 24, 2020
Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditionsKayleigh L Thirlwell, David Colligan, Joanne C Mountford, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2020
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trialEmily A Hewson, Doan T Nguyen, Ricky O'Brien, et al.
Pageof 202